CCA
GILD icon

Canyon Capital Advisors’s Gilead Sciences GILD Stock Holding History

Canyon Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-690,621
Closed -$54.6M – 46
2016
Q3 		$54.6M Sell
690,621
-133,976
-16% -$10.9M 1.99% 11
2016
Q2 		$68.8M Sell
824,597
-10,737
-1% -$953K 2.74% 10
2016
Q1 		$76.7M Sell
835,334
-10,825
-1% -$976K 3.06% 9
2015
Q4 		$85.6M Sell
846,159
-3,511
-0.4% -$365K 2.63% 11
2015
Q3 		$83.4M Buy
849,670
+43,960
+5% +$4.88M 2.29% 14
2015
Q2 		$94.3M Sell
805,710
-160,903
-17% -$17.6M 2.49% 11
2015
Q1 		$94.9M Buy
+966,613
New +$98.2M 2.97% 8

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Canyon Capital Advisors's GILD Position: Q4 2016 in Review

Canyon Capital Advisors sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 690,621 shares — an estimated $54.6M sold.

Canyon Capital Advisors first reported a position in GILD in Q1 2015 and held it in 7 quarters. The position peaked at $94.9M in Q1 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Canyon Capital Advisors reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Canyon Capital Advisors sold 690,621 Gilead Sciences shares in Q4 2016, an estimated $54.6M.
  • Canyon Capital Advisors first reported a position in Gilead Sciences in Q1 2015 and held it in 7 quarters.
  • Canyon Capital Advisors's Gilead Sciences position peaked at $94.9M in Q1 2015.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Canyon Capital Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.